Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes

← Back to all presentations

Next-Generation Menin Inhibitor KO-7246 Regenerates βCell Mass in Diabetic Rodent and Human Islet Models

Asako McCloskey, Yahu Liu, and Francis Burrows

2026 European Association for the Study of Diabetes (EASD)